# CVRx Inc. (CVRX)

Source: https://www.quantisnow.com/company/CVRX
Generated: 2026-11-09T18:28:27.366Z

- Ticker: CVRX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2021
- SEC CIK: 0001235912

## Latest CVRX news and filings

- 2026-11-06 12:40 UTC [Analyst Downgrade] [CVRx, Inc. downgraded by Canaccord Genuity with a new price target](https://www.quantisnow.com/insight/cvrx-inc-downgraded-by-canaccord-genuity-with-a-new-price-6778038)
- 2026-11-06 12:27 UTC [Analyst Downgrade] [CVRx, Inc. downgraded by William Blair](https://www.quantisnow.com/insight/cvrx-inc-downgraded-by-william-blair-6777964)
- 2026-11-05 21:44 UTC [SEC Form S-8] [SEC Form S-8 filed by CVRx Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-cvrx-inc-6777127)
- 2026-11-05 21:17 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by CVRx Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cvrx-inc-6776732)
- 2026-11-05 21:10 UTC [SEC Form 8-K] [CVRx Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cvrx-inc-filed-sec-form-8-k-results-of-operations-and-6776483)
- 2026-11-05 21:05 UTC [Earnings Date] [CVRx Reports Third Quarter 2026 Financial and Operating Results](https://www.quantisnow.com/insight/cvrx-reports-third-quarter-2026-financial-and-operating-results-6776065)
- 2026-11-02 21:01 UTC [Conference Announcement] [CVRx to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/cvrx-to-participate-in-upcoming-investor-conferences-6766917)
- 2026-10-22 20:30 UTC [Earnings Date] [CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026](https://www.quantisnow.com/insight/cvrx-to-report-third-quarter-2026-financial-and-operating-results-6755301)
- 2026-09-21 20:13 UTC [SEC Form 8-K] [CVRx Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cvrx-inc-filed-sec-form-8-k-leadership-update-financial-statements-6721681)
- 2026-09-21 20:07 UTC [Leadership Update] [CVRx Appoints John Landry as Chief Financial Officer](https://www.quantisnow.com/insight/cvrx-appoints-john-landry-as-chief-financial-officer-6721631)
- 2026-08-25 12:00 UTC [CVRx Responds to Letter from Pointillist Family Office](https://www.quantisnow.com/insight/cvrx-responds-to-letter-from-pointillist-family-office-6693624)
- 2026-08-24 12:30 UTC [Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer](https://www.quantisnow.com/insight/jorey-chernett-owner-of-more-than-55-of-outstanding-shares-6692212)
- 2026-08-24 12:30 UTC [CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy](https://www.quantisnow.com/insight/cvrx-announces-devoted-health-medicare-advantage-coverage-policy-for-barostim-6692195)
- 2026-08-14 00:18 UTC [Insider Buy] [CHIEF OPERATING OFFICER Binkowski Brent bought $76,432 worth of shares (26,223 units at $2.91), increasing direct ownership by 87% to 56,514 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-binkowski-brent-bought-76432-worth-of-shares-6681546)
- 2026-08-13 20:26 UTC [SEC Form 4] [CHIEF OPERATING OFFICER Binkowski Brent sold $3,338 worth of shares (1,309 units at $2.55), decreasing direct ownership by 4% to 30,291 units (SEC Form 4) (tax liability)](https://www.quantisnow.com/insight/chief-operating-officer-binkowski-brent-sold-3338-worth-of-shares-6680803)
- 2026-08-11 11:09 UTC [SEC Form 8-K] [CVRx Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cvrx-inc-filed-sec-form-8-k-leadership-update-financial-statements-6674898)
- 2026-08-11 11:00 UTC [Leadership Update] [CVRx Announces Sales Leadership Transition](https://www.quantisnow.com/insight/cvrx-announces-sales-leadership-transition-6674824)
- 2026-08-07 12:44 UTC [Analyst Downgrade] [CVRx, Inc. downgraded by Craig Hallum with a new price target](https://www.quantisnow.com/insight/cvrx-inc-downgraded-by-craig-hallum-with-a-new-price-6670806)
- 2026-08-07 12:40 UTC [Analyst Downgrade] [CVRx, Inc. downgraded by Lake Street with a new price target](https://www.quantisnow.com/insight/cvrx-inc-downgraded-by-lake-street-with-a-new-price-6670792)
- 2026-08-07 12:21 UTC [Analyst Downgrade] [CVRx, Inc. downgraded by Piper Sandler with a new price target](https://www.quantisnow.com/insight/cvrx-inc-downgraded-by-piper-sandler-with-a-new-price-6670707)
- 2026-08-06 20:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by CVRx Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cvrx-inc-6669271)
- 2026-08-06 20:11 UTC [SEC Form 8-K] [CVRx Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cvrx-inc-filed-sec-form-8-k-results-of-operations-and-6669102)
- 2026-08-06 20:05 UTC [Earnings Date] [CVRx Reports Second Quarter 2026 Financial and Operating Results](https://www.quantisnow.com/insight/cvrx-reports-second-quarter-2026-financial-and-operating-results-6668738)
- 2026-07-28 12:30 UTC [Conference Announcement] [CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference](https://www.quantisnow.com/insight/cvrx-to-present-at-canaccord-genuitys-46th-annual-growth-conference-6650835)
- 2026-07-23 20:30 UTC [Earnings Date] [CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026](https://www.quantisnow.com/insight/cvrx-to-report-second-quarter-2026-financial-and-operating-results-6647254)
- 2026-06-09 12:00 UTC [SEC Form 8-K] [CVRx Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cvrx-inc-filed-sec-form-8-k-leadership-update-financial-statements-6594612)
- 2026-06-09 11:30 UTC [Public Offering] [CVRx Announces Chief Financial Officer Transition](https://www.quantisnow.com/insight/cvrx-announces-chief-financial-officer-transition-6594513)
- 2026-06-03 22:06 UTC [SEC Form 4] [Director Nielsen Kirk G. was granted 8,720 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-nielsen-kirk-g-was-granted-8720-shares-sec-form-6587971)
- 2026-06-03 22:06 UTC [SEC Form 4] [Director Jain Mudit K. was granted 8,720 shares, increasing direct ownership by 154% to 14,370 units (SEC Form 4)](https://www.quantisnow.com/insight/director-jain-mudit-k-was-granted-8720-shares-increasing-direct-6587968)
- 2026-06-03 22:05 UTC [SEC Form 4] [Director Slattery Joseph P was granted 8,720 shares, increasing direct ownership by 28% to 39,365 units (SEC Form 4)](https://www.quantisnow.com/insight/director-slattery-joseph-p-was-granted-8720-shares-increasing-direct-6587964)
- 2026-06-03 22:05 UTC [SEC Form 4] [Director Hill, Mitch C. was granted 8,720 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-hill-mitch-c-was-granted-8720-shares-sec-form-6587963)
- 2026-06-03 22:05 UTC [SEC Form 4] [Director Ballinger Kevin J. was granted 8,720 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-ballinger-kevin-j-was-granted-8720-shares-sec-form-6587961)
- 2026-06-03 22:04 UTC [SEC Form 4] [Director Shadan Martha was granted 8,720 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-shadan-martha-was-granted-8720-shares-sec-form-4-6587960)
- 2026-06-03 22:03 UTC [SEC Form 4] [Director Dale Michael D was granted 29,005 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-dale-michael-d-was-granted-29005-shares-sec-form-6587955)
- 2026-06-03 21:55 UTC [SEC Form 3] [SEC Form 3 filed by new insider Dale Michael D](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-dale-michael-d-6587922)
- 2026-06-03 20:49 UTC [SEC Form 8-K] [CVRx Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/cvrx-inc-filed-sec-form-8-k-submission-of-matters-to-6587453)
- 2026-05-28 21:06 UTC [SEC Form SD filed by CVRx Inc.](https://www.quantisnow.com/insight/sec-form-sd-filed-by-cvrx-inc-6577686)
- 2026-05-27 20:30 UTC [Conference Announcement] [CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference](https://www.quantisnow.com/insight/cvrx-to-present-at-the-goldman-sachs-47th-annual-global-6575048)
- 2026-05-20 20:30 UTC [Conference Announcement] [CVRx to Present at the William Blair 46th Annual Growth Stock Conference](https://www.quantisnow.com/insight/cvrx-to-present-at-the-william-blair-46th-annual-growth-6565356)
- 2026-05-14 12:00 UTC [CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy](https://www.quantisnow.com/insight/cvrx-announces-humana-medicare-advantage-coverage-policy-for-barostim-therapy-6552461)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CVRX
- Earnings history: https://www.quantisnow.com/earnings/CVRX
- Dividend history: https://www.quantisnow.com/dividends/CVRX
- Insider transactions: https://www.quantisnow.com/insiders/CVRX
- Options chain: https://www.quantisnow.com/options/CVRX
- SEC 8-K filings only: https://www.quantisnow.com/company/CVRX/8-k
- RSS and alerts for CVRX: https://www.quantisnow.com/docs/rss-feeds.md